The present study documents the traditional knowledge and micropropagation strategies of medicinal plants belonging to family Asclepiadaceae with particular emphasis on a well-studied medicinal plant Gymnema sylvestre R.Br. The family Asclepiadaceae comprises about 320 genera and 2700 species. Due to the elevated market demand of the medicinal plants belonging to family Asclepiadaceae, most of the species are endangered, threatened, rare or critically endangered. The species of the family are also exploited locally due to their high medicinal value and other etanobotanical properties. There are other constrains as well which impede their abundance in nature including low seed germination and poor vegetative propagation. In this direction various in vitro micropropagation protocols have been established from time to time on a range of species of the family Asclepiadaceae. Present review thus emphasizes on medicinal importance and in vitro micropropagation studies on various plants of family Asclepiadaceae with special reference to Gymnema sylvestre. Gymnema sylvestre (Hindi: Gurmar) is a medicinal plant of immense pharmaceutical value, but it is disappearing fast from its natural habitat. The species is threatened with extinction due to its indiscriminate collection as raw material for pharmaceutical industry, where it is used for manufacturing of drugs for diabetes, asthma, eye complaints, etc. So, present study was designed to provide an overview that can serve as a data base and prospective guide on medicinal importance and micropropagation studies on family Asclepiadaceae in general and Gymnema sylvestre in particular.
Introduction
Every civilization has a history of using medicinal plants and their products since time immemorial. In ancient times, Egyptian, Indian, Chinese, Africans and others used a variety of plant products for curing most of the ailments [1] . Moreover, modern pharmacopoeia still contains at least 25% of drugs derived directly from plants, and many others, which are synthetic analogues, built on the prototype compounds isolated from plants. The WHO estimates have reported that 80% of the world's populations rely on plant based traditional medicine for their primary health care [2] .
It is well known that plants possess an unlimited source of phytochemicals, which exhibit remarkable bioactive compounds used for medicines to cure various ailments like cancer, AIDS, hepatitis, diabetes, rheumatoid, arthritis and malaria [3] . World is endowed with a rich wealth of medicinal plants and herbs have always been the principal form of medicine in India [4] .
Advances in Biomedicine and Pharmacy (An International Journal of Biomedicine, Natural Products and Pharmacy)
Medicinal plants are gaining popularity throughout world and among the developed nations, as everyone strives to stay healthy on the face of chronic stress and pollution and to treat illness with medicines that work in concert with the body's own defense system. Nevertheless, with increasing realization of the health hazards and toxicity associated with the indiscriminate use of synthetic drugs and antibiotics, the interest in the use of plant based drugs has been globally revived [5] . People in Europe, North America and Australia are consulting trained herbal professionals of developing countries and using herbal medicines [6] . Folk medicines are also getting popularity nowadays, and significantly contribute to Ayurvedic, Unani and traditional Chinese medicines to a great extent.
India has 2.4% of world's area with 8% of global biodiversity. It is one of the 12 mega diversity centers having over 45,000 plant species. Its diversity is unmatched due to the presence of 16 different agro climatic zones, 10 vegetative zones and 15 biotic provinces [7] . The country accounts for 17,500 species of higher plants. Of these, more than 2,000 species are documented for medicinal value vis-à-vis 1,100 species are used in different systems of medicines. Out of these, 600-700 species are locally used in the country and 150 species with commercial usage [8] . Macro-analysis of the distribution of medicinal plants shows that they are distributed across diverse habitats and landscape elements. Around 70% of India's medicinal plants are found in tropical areas mostly in various forest types spread across the western and Eastern Ghats, the Vindhyas, Chotta Nagpur plateau, Aravalis and Himalayas and 30% of the medicinal plants, in the temperate and alpine areas and higher altitude [9] .
Furthermore, from last century, there has been a rapid extension of the allopathic system of medical treatment which has led to the generation of commercial demand in national and international market for pharmacopoeia drugs and their products of plant origin. In some developing countries, plant based traditional medicines are main source for primary health care Fig. 1 [10] .
International trade in medicinal plants and phytopharmaceutical preparations is a major force in the world economy and demand is increasing in both developing and industrialized nations. A report prepared by the Export-Import Bank of India has estimated that the international market of medicinal plant-related products is in the range of US$ 60 billion with an annual growth at the rate of 7%.The current global market is pegged at US$ 62 billion [11] . A dramatic increase in exports of medicinal plants attests to India's interest in these products.
According to the Export-Import Bank of India, India's share in the global herbal market in the year 2001 was of the order of US$ 1 billion. India is the second largest exporter, next to China. USA is the principal market for Indian medicinal plants, accounting for about 50% of exports. The value of traded medicinal plants in the domestic market was about Rs. 348 crore, in the year 2001. The value of domestic trade, along with the export level of Rs. 463 crore, made the commercialization of Indian medicinal plants to the tune of Rs. 847 crore in the year 2001-02 (www.vasundharaorissa.org). Thus, the export of medicinal from India appears to be growing very fast [12] . Consequently, the National Medicinal Plant Board, under the Union Government of India Ministry of Health and Welfare has decided to set up Export Promotion zone exclusively for medicinal plants [13] .
Global trends of herbal market
Herbal drugs are not prescribed in the western countries, unless they are adequately standardized in the allopathic way. On the other hand, the scope of herbal drug marketing is better in the developing as well as under developed countries, where the norms are not so strict and also the modern system is yet to completely dominate over the traditional systems. Whenever the global trend of the herbal market is discussed, although in the first place it seems to be concerned about the quantitative increase or decrease in the demand and supply status of herbal materials; the actual emphasis is on the value of trading. It is in this latter context that the role of western countries becomes important as the value of trading becomes significantly higher with respect to the marketing in these countries. In terms of the value of export-import, Hong Kong (17%) plus mainland China (4%) had the largest share (21%) in the import market followed by USA (14%) and Japan (10%) in 2001 (w.w.w.vasundharaorissa.org). Leading markets of herbal products in Europe are Germany followed by France, UK and Italy. Germany has the largest herbal extraction industry in Europe and USA, the major market for essential oils and herbal tea (w.w.w.vasundharaorissa.org). While 80% of the world population still uses traditional medicines, the interest in alternative medicines in the developed countries has increased by 60% since 1989. In USA, consumer use of herbal products was less than 5% in 1991 which had increased to 50% in 2004.WHO estimated the world market for herbal products to be the worth of US$ 62 billion and would hit US$ 5 trillion by 2050.The market is growing @ 7% per annum [13] 
The Indian scenario
In India, traditional systems of medicine have recognized and used over 7500 species of medicinal plants out of which Ayurveda uses about 1769 species. Figure 2 shows the trend in the export of Ayurvedic and Unani herbs under the unspecified category.
Thus, the record indicates dwindling export of medicinal herbs from India possibly due to non-systematic collection and processing of the produce by disorganized sector, involving tribals and market regulators. In this direction authors attempt to review the status, medicinal properties, conservation approach and judicious use of some medicinal plants belonging to family Asclepiadaceae. The current endeavor can act as a prospect for sustainable use of some medicinally important plants of this family in current future. The medicinal values of some of the important members of family Ascalpiadaceae is given in tabulated form in Table 1 .
The conservation of medicinal plants belonging to family Asclepiadaceae is very important due to their poor regenerative capacity through vegetative propagation and stumpy seed germination. The conservation approach through in vitro regeneration and multiplication is thus only viable option. Taking this under consideration, authors here described various media with different phytoharmonal combinations used for the in vitro regeneration of family Ascalpiadaceae. 
Studies of micropropagation in Asclepiadaceae family
The family Asclepiadaceae comprises about 320 genera and 2700 species [40] . Asclepias curassavice Pramanik and Datta (1986) [41] investigated clonal propagation of medicinal milkweed (Asclepiascurassavice L) by culturing excised node on Murashge and Skoog (MS) medium supplemented with different hormone combinations. Both Benzoaminopurine (BA) and kinetin (Kn) were found equally effective for shoot initiation. Indole Acetic acid (IAA) and Naphthalene acetic acid (NAA) were found suitable for root induction. Combinations of Kn and NAA resulted in the induction of both roots and shoots after 30 days of culture. Chromosomal variation was observed in the roots of in vitro regenerated plants. Regenerants with higher chromosome number (33; 2n = 22) obtained on MS medium in response to 9.2 µM Kn + 10.7 µM NAA showed vigorous and higher propagation rates than the aneuploid plants possessing less than the diploid chromosome number (2n -2 = 20, 2n -4 = 18). Such variations are more likely due to genetic fitness of deficiency among different aneuploids grown on particular nutrient medium.
Ceropegia spp
Vishwanath (1998) [42] developed in vitro techniques for conserving wild and endemic species of Ceropegia (C.
jainii, C. Bulbosa var. bulbosa and C. bulbos).
Nodal explants of all species were cultured on 0.5x MS medium with 8.8 µM BA to regenerate the axillary buds. These buds produced multiple shoots when transferred to multiplication medium consisting of 0.5x MS medium with 2.2 µM BA, or micro-tubers when transferred to 0.5x MS medium with 22.2 µM BA and 23.2 µM Kn. In vitro flowering occurred in Ceropegia jainii on spermine at 0.25 µM as an additive and not in C. bulbosa. Rooting of the shoots was possible both by in vitro and ex vitro means. Botta et al. (2003) [43] developed a rapid micropropagation system for Ceropegia bulbosa. First five nodes of 1.0 cm each, harvested from young healthy shoots from garden raised plants, were cultured on B 5 medium supplemented with different concentrations of BA and Adenine sulphate (Ads) each in combination with 0.268 µM NAA. Multiple shoot formation of up to 12 shoots was observed within one week in the presence of 13.32 µMBA and 0.268 µM NAA. Shoots were multiplied by subculture on the same medium. Shoots of 3-4 cm length were rooted in the medium supplemented with 9.84 µM IBA. The rooted plantlets were hardened and successfully established in pots with 70% success rate. In vitro flowering was observed at 2.22 µM BA + 2.89 µM GA 3 . Shoots transferred to the medium containing 0.232 µM Kn + 9.84 µM IBA showed formation of micro-tubers in 28 days, while the shoots cultured in the presence of 2.89 µM GA 3 + 2.22 µM BA showed 76 % flowering leading to seed production with 65% germinability. [44] proposed protocol for in vitro propagation of Ceropegia candelabrium L. through axillary bud multiplication. MS medium with 8.87µM BA and 2.46 µM IBA was best suited for axillary bud proliferation, inducing a mean of eight shoots per node. Excision and culture of the nodal segments from in vitro shoots on fresh medium with the same concentrations of BA and IBA facilitated 10 shoots node. Subsequent cultures enhanced the shoot proliferation rate. Shoots developed were rooted on half strength MS medium with 0.49 µM IBA. Starting from a single node explants, 250 rooted explants, i.e. plantlets were obtained within 120 days. Plantlets established in the pots exhibited 90 % survival. Plantlets successfully established in the field exhibited morphological characters identical to mother plants. Ramulu et al. (2002) [45] obtained a rapid in vitro clonal propagation of Cynanchum callialatum Buch.-Ham., using shoots from aseptic seedlings. Defoliated nodal segments of 60 days old aseptic seedlings were cultured on MS medium supplemented with different concentrations of BA/Kn alone or in combination with various auxins and growth adjuvants. The highest number of shoots (3.05 ± 0.94) was obtained on the medium fortified with 4.44 µM BA + 2.32 µM Kn + 1.44µM GA 3 + 284 µM ascorbic acid + 10% coconut milk. The regenerated shoots were rooted the best on half strength MS medium containing 5.71 µM IAA+ 0.93 µM Kn. Plantlets with well-developed roots were successfully transferred to soil and 85% of the transferred plants survived.
Cynanchum callialatum

Cryptolepis buchanani
Prasad et al. (2004) [46] standardized in vitro regeneration protocol for multiplication of Cryptolepis buchanani by using shoot tip, cotyledonary node and nodal explants derived from seedlings grown in vitro. The best response was achieved with nodal explants. Cultures were established placing the nodal explants on MS medium supplemented with various cytokinins singly or in combination with auxin and gibberellin. Of the various cytokinins used singly or in combination with auxins, BA was found to be the most effective for shoot proliferation. The maximum number of shoots (12.5-13.0 shoots per explant with shoot length of 4.5-5.0 cm) was produced on MS medium fortified with 8.88 µMBA, 0.465 µM Kn, 0.268 µM NAA and 0.144 µM GA 3 with 60% response. Individual shoots (grown on shoot proliferation medium) were rooted on MS medium supplemented with various auxins IAA, IBA, NAA singly or in combination. Of these, IBA at 4.92 µM resulted in 80% rooting and about 6.5-7.0 roots per shoot of length 4.0-4.5cm. The in vitro raised plantlets were acclimatized successfully to pots containing a mixture of autoclaved peatmoss and compost in 1:1 ratio. Reddy et al. (2002) [47] [48] reported an efficient protocol for successful micropropagation system for Decalepis hamiltoni ('swallow root'), through shoot multiplication. The influence of 2.5-7.5 µM 2-iP, 4.4-17.7 µM BAP, 2.3-4.7 µM Kn, 2.8-6.8 µM (Thidiazuron) TDZ and 2.3-11.4 µM zeatin alone and in combination with 0.3-0.9 µM IAA on in vitro multiple shoot production was studied by using semi-solid MS medium. The maximum number of multiple shoots (6.5±0.4) was induced from shoot tips cultured on MS medium containing 4.9µM 2-iP. But both 9.1 µM zeatin and 4.7 µM Kn in combination with 0.6 µM IAA were able to produce a maximum of 5.0 ± 0.4 and 5.1 ± 0.4 multiple shoots, respectively. Further elongation of shoots and adventitious shoot formation was obtained on the medium containing 2.5 µM GA 3 Cotyledonary nodal explants cultured in the same medium showed multiple shoot formation and axillary branching. But the shoots were thin, fragile and not suitable for mass propagation. Single nodes of a solitary shoot sub-cultured on MS medium containing 2.22 µM BA and 0.24 µM 2-iP together produced 9.8 ± 0.3 nodes on 18.0 ± 0.6 cm long shoots within on 5-6 weeks. The basal nodes of the shoots so formed were repeatedly subcultured to increase the stock of propagules while the 2.5-3.0cm terminal cuttings were used for rooting. The best root induction (68%) and survival (86%) was achieved on half strength MS medium with 1.07 µM NAA. Field established plants showed uniform growth and phenotypic similarity to parental stock.
Decalepis hamiltonii
Gymnema ssp
Komalavalli and Rao (1997) [22] studied the collection season, nature and size of the explant, nodal position, plant growth regulators and certain additives (ascorbic acid, coconut milk, gibberlic acid) on in vitro clonal propagation of Gymnema elegans. Maximum number of shoots were induced from seedling and mature axillary nodes on MS medium containing 13.0 µM BA + 2.0 µM Kn + 3.0 µM NAA + 568 µM ascorbic acid + 10% coconut milk + 1.0 µM GA 3. The in vitro raised shoots were rooted on MS medium supplemented with13.0 µM IBA. The plantlets, thus developed, were hardened and successfully established in the soil. Reddy et al. (1998) [50] developed a rapid system for regenerating shoots from mature nodal explants of Gymnema sylvestre. Single node stem explants were inoculated on MS medium containing different combinations of BA or Kn with NAA. Maximum number of shoots (7 per explant) were observed on the medium containing 22.2 µM BA and 1.074 µM NAA. Regenerated shoots were rooted on MS half-strength medium without supplementing any growth regulator.
Komalavalli and Rao (2000) [51] [64] established in vitro raised shoot culture of Tylophora indica on MS medium with 11.1 µM BA and 0.751 µM IAA. An excellent rate of shoot multiplication was achieved. The tissue culture-generated shoots were rooted on the medium containing IAA. A highly regenerative system was developed by using leaf explants from mature plant. This system can be effectively used to multiply the plant material.
Gymnema sylvestre R.Br. (2N=22)
Gymnema sylvestre is a vulnerable woody and highly branched climber vine run over the top of tall trees. It is a potent anti-diabetic plant used in folk, Ayurvedic, sidda and homeopathic systems of medicine. The active ingredient is gymnemic acid. Various closely related components of gymnemic acid are used for diabetes in pharmaceutical industry all over the globe. Famous pharmaceutical products known in Indian market are gymnema herbal tea, dia-botica capsules. The entire plant is used as a medicine. Following are some of the medicinal uses of Gymnema sylvestre. 9. It treats sore eyes, opacities of lens and cornea as well as acts as stomach stimulant and laxative, curing burning sensation in throat and stomach and family planning [51] .
10. This plant is also used for controlling obesity in the form of Gymnema tea. [73] .
Due to its immense pharmaceutical properties, it has gained tremendous popularity and market demand. The market cost of Gymnema concentrated extracts of one kg obtained from 25 kg or 100 kg of crude drug is Rs. 225.00 or Rs. 480.00 [74] . The leaf powder has been exported to USA, Europe, Japan and Middle-east countries. Most of the Ayurvedic as well as allopathic pharmaceutical companies also require sufficient quantity of Gymnema powder for preparation of medicine. Thus, the demand of Indian Gymnema is increasing in the international market. As revealed by (Fig. 5) , the export was 70,000 kg during 1996-1997. The decreasing trend of export was observed from 1998-2002 due to short supply of Gymnema sylvestre powder.
Photochemistry of Gymnema sylvestre
The above discussed pharmacological properties of G. sylvestre are due to the presence of active ingredients commonly known as secondary metabolites. The leaves of Gymnema sylvestre contain gymnemic acid as a major bioactive component [75] , which is a mixture of tri-terpene saponins of closely related structure e.g., Triterpene saponins, Oleanane saponins, Dammarene saponins, Gurmarin, Triterpenoid saponins, Gymnemasins A-D, Gymnemanol (aglycone), Gymmestrogenin, Flavonol glycoside, Sterols, Quercitol, Lupeol, Parabin, Conduritol A and Quercitol. Other than gymnemic acid the prominent metabolite in the species, various other chemical compounds isolated and characterized in G. sylvestre are given below.
The low seed germination, vegetative propagation and indiscriminate use of G sylvestre has led it to the category of threatened species. Thus the only alternative method for conservation and large scale propagation of the species is in vitro micropropagation. 
Conclusion
The extensive literature survey exposed Asclepiadaceae as an important medicinal plant family with diverse ethnomedicinal and pharmacological properties. Various biological studies have been dedicated to this family, but a small number of them are useful in evaluating its traditional uses. The species of this family illustrates the occurrence of countless natural ingredients which are responsible for wide-range of pharmacological and medicinal properties. In future research work, the evaluation needs to be carried out on Asclepiadaceae family in general and G. sylvestre in particular. In addition the medicinal plants of the family should be characterized chemically in order to get medicinal preparations and in order to use these preparations for their practical clinical applications. The potential plants of the family like G. sylvestre should be selected and characterized using chemical and molecular approaches. Moreover the efficient in vitro multiplication of the important threatened plants of the family should be established. The better cultivars of the plants should be developed using sophisticated molecular approaches. Genetic engineering using recombinant DNA technology can serve as a useful tool for the elucidation and up regulation of the important genes associated with a particular biosynthetic pathway of the compound of interest. In nutshell, there is wide scope in pharmacological investigation of family Asclepiadaceae. The need of the hour is taking positive measures for the exploitation, conservation and sustainable use of family Asclepiadaceae.
